Ministers Agree on 5%-Plus Price Discrepancy Line for Off-Year Re-Pricing; 59% Coverage for Innovative Meds, 88% for LLPs, 83% for Gx

Health Minister Norihisa Tamura (left), Finance Minister Taro Aso Hammer Out Framework of FY2021 Off-Year Re-Pricing on Dec. 17 (Courtesy of MOF) Japan’s health and finance ministers on December 17 officially agreed to conduct the first “off-year” drug re-pricing on...read more